Capital DailyCapital Daily
Markets · Investing · Business
Capital DailyCapital Daily
Finance

Why Pacira BioSciences Skyrocketed Today

The specialty pharmaceutical company is being acquired.

Why Pacira BioSciences Skyrocketed Today

Published October 8, 2026 · Category: Finance

Overview

Shares of Pacira BioSciences skyrocketed on Thursday, rising as much as 44.2%. As of 10:58 a.m. ET, the stock was still up 44.1%.

The catalyst that sent the specialty healthcare provider higher was news of its acquisition.

Details

Continue reading

Source

Originally published at www.fool.com.

Related Articles

CD
Capital Daily Newsroom

Capital Daily covers markets, crypto and commodities for Asia & the Middle East — tier-1 desk research, AI-driven analysis, institutional-grade data. Tip our newsroom: [email protected]

Email the newsroom →
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.